BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11846045)

  • 21. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
    Okuducu AF; Zils U; Michaelis SA; Mawrin C; von Deimling A
    Cancer; 2006 Sep; 107(6):1365-72. PubMed ID: 16894529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optic nerve sheath meningiomas].
    Litre CF; Colin P; Rousseaux P; Civit T
    Neurochirurgie; 2010; 56(2-3):132-6. PubMed ID: 20227092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44 expression in human meningiomas: an immunohistochemical analysis.
    Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
    Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100A5: a marker of recurrence in WHO grade I meningiomas.
    Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multisession CyberKnife radiosurgery for optic nerve sheath meningiomas.
    Romanelli P; Wowra B; Muacevic A
    Neurosurg Focus; 2007; 23(6):E11. PubMed ID: 18081476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic optic nerve sheath meningioma.
    Rosca TI; Carstocea BD; Vlãdescu TG; St Tihoan C; Gherghescu GG
    J Neuroophthalmol; 2006 Jun; 26(2):121-2. PubMed ID: 16845313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
    Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optic nerve sheath meningiomas--non-surgical treatment.
    Smee RI; Schneider M; Williams JR
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):8-13. PubMed ID: 19019641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral primary optic nerve sheath meningiomas with pneumosinus dilatans.
    Nair A; Behari S; Jain M; Jaiswal AK
    Acta Neurochir (Wien); 2011 Dec; 153(12):2495-7. PubMed ID: 21892635
    [No Abstract]   [Full Text] [Related]  

  • 31. Optic nerve sheath meningioma detected by single- photon emission computed tomography/computed tomography somatostatin receptor scintigraphy: a case report.
    Nussbaum-Hermassi L; Ahle G; Zaenker C; Duca C; Namer IJ
    J Med Case Rep; 2016 Apr; 10(1):96. PubMed ID: 27103315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
    Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
    J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of progesterone receptor status in meningiomas.
    Roser F; Nakamura M; Bellinzona M; Rosahl SK; Ostertag H; Samii M
    J Clin Pathol; 2004 Oct; 57(10):1033-7. PubMed ID: 15452155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pediatric optic nerve sheath meningioma with intraocular extension].
    Kharrat O; Leruez S; Graffe A; Michalak-Provost S; Milea D
    J Fr Ophtalmol; 2016 Mar; 39(3):e69-72. PubMed ID: 26850506
    [No Abstract]   [Full Text] [Related]  

  • 35. Optic nerve sheath meningiomas: clinical features, functional prognosis and controversial treatment.
    Castel A; Boschi A; Renard L; De Potter P
    Bull Soc Belge Ophtalmol; 2000; 275():73-8. PubMed ID: 10853310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
    Takei H; Buckleair LW; Powell SZ
    Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of surgery in meningiomas involving the optic nerve sheath.
    Roser F; Nakamura M; Martini-Thomas R; Samii M; Tatagiba M
    Clin Neurol Neurosurg; 2006 Jul; 108(5):470-6. PubMed ID: 16191463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of oestrogen and progesterone receptors in meningiomas by a technique utilizing the binding hormones in a polymerized state.
    Kumar S; Mandal AK; Mandal A; Puri V; Aggarwal SP; Mehndiratta M
    Indian J Pathol Microbiol; 1995 Apr; 38(2):189-92. PubMed ID: 8919108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
    Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
    Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resection of optic nerve sheath meningioma via transcranio-orbital approach].
    Zhang TM; An YZ; Shi JT; Zhang JL; Li Y
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2559-61. PubMed ID: 16321303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.